Keiretsu Forum — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases.
BiotechHealthtechMedical DevicesAustin, US
Matt Pauls(Chair of the Board of Directors and Chief Executive Officer)Mike Ciesla(Executive Officer)Badrul Chowdhury(Executive Officer)Richard J. Hawkins(Director)An van Es-Johansson(Director)Ricky Sun(Director)
Co-investorsBain Capital Life SciencesCentral Texas Angel NetworkGreen Park & Golf VenturesMoore Venture PartnersNew Enterprise Associates (NEA)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.